Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.
Agarwal MA, Fonarow GC, Ziaeian B. National trends in heart failure hospitalizations and readmissions from 2010 to 2017. JAMA Cardiol. 2021;6(8):952–6.
Bhatnagar R, Fonarow GC, Heidenreich PA, Ziaeian B. Expenditure on heart failure in the United States: the medical expenditure panel survey 2009–2018. JACC Heart Fail. 2022;10(8):571–80.
Article PubMed PubMed Central Google Scholar
Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004–2016. BMC Cardiovasc Disord. 2018;18(1):74.
Article PubMed PubMed Central Google Scholar
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–87.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032.
Reeves RA, Halpern EJ, Rao VM. Cardiac imaging trends from 2010 to 2019 in the medicare population. Radiol Cardiothorac Imaging. 2021;3(5):e210156.
Article PubMed PubMed Central Google Scholar
Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64.
Cameli M. Echocardiography strain: why is it used more and more? Eur Heart J Suppl. 2022;24(Suppl I):I38–42.
Article PubMed PubMed Central Google Scholar
Muraru D, Cecchetto A, Cucchini U, Zhou X, Lang RM, Romeo G, et al. Intervendor consistency and accuracy of left ventricular volume measurements using three-dimensional echocardiography. J Am Soc Echocardiogr. 2018;31(2):158–168 e1.
Bhatia RS, Farkouh M, Ivers N, Yin XC, Myers D, Nesbitt G, et al. Improving the appropriate use of transthoracic echocardiography-the results of the echo WISELY trial. Eur Heart J. 2017;38:1089–1089.
Paulraj S, Kumar PA, Byrnes S, Ojha N, Singh A, Raj V. A quality improvement initiative for echocardiogram ordering patterns in an Academic Hospital. Cureus J Med Sci. 2024;16(1):e52717.
Mehta M, Jacobson T, Peters D, Le E, Chadderdon S, Allen AJ, et al. Handheld ultrasound versus physical examination in patients referred for transthoracic echocardiography for a suspected cardiac condition. JACC Cardiovasc Imaging. 2014;7(10):983–90.
Barry T, Farina JM, Chao CJ, Ayoub C, Jeong J, Patel BN, et al. The role of artificial intelligence in echocardiography. J Imaging. 2023;9(2):50.
Article PubMed PubMed Central Google Scholar
Madani A, Arnaout R, Mofrad M, Arnaout R. Fast and accurate view classification of echocardiograms using deep learning. NPJ Digit Med. 2018;1(1):6.
Article PubMed PubMed Central Google Scholar
He BY, Kwan AC, Cho JH, Yuan NL, Pollick C, Shiota T, et al. Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature. 2023;616(7957):520–4.
Article CAS PubMed PubMed Central Google Scholar
Liu BH, Chang H, Yang D, Yang FF, Wang QS, Deng YJ, et al. A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection. Sci Rep. 2023;13(1):3.
Article CAS PubMed PubMed Central Google Scholar
Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, et al. Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):87.
Article PubMed PubMed Central Google Scholar
Joshi SB, Connelly KA, Jimenez-Juan L, Hansen M, Kirpalani A, Dorian P, et al. Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson. 2012;14(1):69.
Article PubMed PubMed Central Google Scholar
• Champ-Rigot L, Gay P, Seita F, Benouda L, Morello R, Pellissier A, et al. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2020;22(1):48. Findings from this study suggest that CMR is more accurate for predicting adverse outcomes when compared to echocardiogram in patients referred for primary prevention ICD.
Article PubMed PubMed Central Google Scholar
Zhao L, Lu A, Tian J, Huang J, Ma X. Effects of different LVEF assessed by echocardiography and CMR on the diagnosis and therapeutic decisions of cardiovascular diseases. Front Physiol. 2020;11:679.
Article PubMed PubMed Central Google Scholar
Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249–54.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020;76(25):3022–55.
Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342(24):1778–85.
Article CAS PubMed Google Scholar
Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118(15):1541–9.
Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. J Am Coll Cardiol. 2017;69(7):761–73.
Ikeda U, Minamisawa M, Koyama J. Isolated left ventricular non-compaction cardiomyopathy in adults. J Cardiol. 2015;65(2):91–7.
Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–46.
Shemisa K, Li J, Tam M, Barcena J. Left ventricular noncompaction cardiomyopathy. Cardiovasc Diagn Ther. 2013;3(3):170–5.
PubMed PubMed Central Google Scholar
Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):101–5.
Grothoff M, Pachowsky M, Hoffmann J, Posch M, Klaassen S, Lehmkuhl L, et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol. 2012;22(12):2699–709.
Article PubMed PubMed Central Google Scholar
Kohli SK, Pantazis AA, Shah JS, Adeyemi B, Jackson G, McKenna WJ, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J. 2008;29(1):89–95.
Tian T, Liu Y, Gao L, Wang J, Sun K, Zou Y, et al. Isolated left ventricular noncompaction: clinical profile and prognosis in 106 adult patients. Heart Vessels. 2014;29(5):645–52.
Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384–98.
Article CAS PubMed Google Scholar
Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112(5):636–42.
Article CAS PubMed Google Scholar
Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation. 2003;108(24):3000–5.
Article CAS PubMed Google Scholar
te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. J Cardiovasc Magn Reson. 2014;16(1):50.
Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, Lazzari M, et al. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol. 2020;319:106–14.
留言 (0)